Abnormal uterine bleeding.
Bradley
Linda D
LD
Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001706:Biopsy; D017115:Catheter Ablation; D003276:Contraceptives, Oral / Q000627:therapeutic use; D003613:Danazol / Q000627:therapeutic use; D004107:Dilatation and Curettage; D004621:Embolization, Therapeutic; D004714:Endometrial Hyperplasia / Q000150:complications; D016889:Endometrial Neoplasms / Q000150:complications; D019160:Endosonography; D004965:Estrogen Antagonists / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use; D006801:Humans; D015907:Hysteroscopy; D016912:Levonorgestrel / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D047648:Perimenopause; D011627:Puberty; D012307:Risk Factors; D016896:Treatment Outcome; D014592:Uterine Hemorrhage / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D014842:von Willebrand Diseases / Q000150:complications
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003276:Contraceptives, Oral; D004965:Estrogen Antagonists; D004967:Estrogens; D007987:Gonadotropin-Releasing Hormone; D016912:Levonorgestrel; D003613:Danazol